O'testosterone, where is thy sting? A Urologist's reflection on testosterone and prostate cancer (2024, Comment in
The Lancet)
Abraham Morgentaler
"In 1941 Huggins and Hodges reported that castration or administration of estrogen caused a new serum biomarker, acid phosphatase, to decrease in men with metastatic prostate cancer (PCa). This was the first treatment for men with advanced PCa, and androgen deprivation remains the mainstay of treatment for these men to this day. They also reported that testosterone (T) injections caused acid phosphatase to rise and concluded that “Cancer of the prostate is activated by androgen injections.” Huggins was awarded the Nobel Prize in Medicine or Physiology in 1966.
For the next 60 years there was a near-complete prohibition against the use of testosterone therapy (TTh) because of the fear that raising serum testosterone would cause de novo PCa or cause rapid, aggressive PCa growth
..."